It is of particular interest because it builds on drugs that already have generic versions in development and would not require a cold chain
GLP-1s are shaping how people eat, drink, shop, and exercise, and brands need to be paying close attention to these trends. Also referencing the KFF survey, Shil Kothari, president at Gateway Health Alliances Inc., Fairfield, Calif., explains that the awareness of GLP-1s mean that beverage manufacturers must play a proactive role in offering solutions that support those using these medications
Drosophila models of amyotrophic lateral sclerosis with defects in RNA metabolism
Association between shared medical appointments and weight loss outcomes and anti-obesity medication use in patients with obesity
Tesamorelin delivers a targeted, measurable reduction in deep belly fat that other peptides do not consistently match
D.GermeyerA.de Barros MachadoA.Do NascimentoT